Free Trial

Arch Therapeutics (ARTH) Stock Chart & Stock Price History

Arch Therapeutics logo
$0.26 +0.07 (+37.86%)
(As of 12/20/2024 05:55 PM ET)

Arch Therapeutics Stock Price Performance

5 Day
Performance
+11.78%
1 Month
Performance
+28.55%
3 Month
Performance
-49.59%
6 Month
Performance
-72.94%
Year-To-Date
Performance
-96.45%
1 Year
Performance
-96.88%
Receive ARTH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Arch Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

ARTH Stock Chart for Sunday, December, 22, 2024

Arch Therapeutics Stock Price History

DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization
12/20/2024$0.19$0.26
+37.86%
$0.30$0.199,853 shs$1.22 million
12/19/2024$0.23$0.19
-18.91%
$0.19$0.19547 shs$884,000.00
12/18/2024$0.23$0.23$0.23$0.174,379 shs$1.09 million
12/17/2024$0.20$0.23
+16.69%
$0.23$0.231,524 shs$1.09 million
12/16/2024$0.25$0.20
-19.87%
$0.27$0.1728,118 shs$935,000.00
12/13/2024$0.22$0.25
+11.81%
$0.25$0.231,304 shs$1.17 million
12/12/2024$0.21$0.22
+4.76%
$0.22$0.179,866 shs$1.04 million
12/11/2024$0.19$0.21
+10.53%
$0.21$0.192,548 shs$996,000.00
12/10/2024$0.20$0.19
-5.00%
$0.19$0.17641 shs$901,000.00
12/09/2024$0.20$0.20
+2.56%
$0.21$0.177,900 shs$948,000.00
12/06/2024$0.18$0.20
+8.33%
$0.20$0.20448 shs$925,000.00
12/05/2024$0.18$0.18
-0.22%
$0.22$0.1821,938 shs$854,000.00
12/04/2024$0.21$0.18
-12.00%
$0.19$0.1764,961 shs$855,000.00
12/03/2024$0.20$0.21
+2.50%
$0.24$0.21415 shs$972,000.00
12/02/2024$0.21$0.20
-6.32%
$0.25$0.1765,962 shs$948,000.00
11/29/2024$0.21$0.21$0.21$0.202,910 shs$1.01 million
11/28/2024$0.21$0.21
-0.01%
$0.21$0.202,910 shs$1.01 million
11/27/2024$0.20$0.21
+6.75%
$0.21$0.202,910 shs$1.01 million
11/26/2024$0.20$0.20$0.20$0.20266 shs$948,000.00
11/25/2024$0.20$0.20$0.20$0.202,390 shs$948,000.00
11/22/2024$0.20$0.20$0.20$0.20475 shs$948,000.00
11/21/2024$0.23$0.20
-13.04%
$0.25$0.2024,817 shs$948,000.00


This page (OTCMKTS:ARTH) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners